APA
Piha-Paul S. A., Oh D., Ueno M., Malka D., Chung H. C., Nagrial A., Kelley R. K., Ros W., Italiano A., Nakagawa K., Rugo H. S., de Braud F., Varga A. I., Hansen A., Wang H., Krishnan S., Norwood K. G. & Doi T. (20210412). Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the KEYNOTE-158 and KEYNOTE-028 studies. : International journal of cancer.
Chicago
Piha-Paul Sarina A, Oh Do-Youn, Ueno Makoto, Malka David, Chung Hyun Cheol, Nagrial Adnan, Kelley Robin K, Ros Willeke, Italiano Antoine, Nakagawa Kazuhiko, Rugo Hope S, de Braud Filippo, Varga Andrea Iolanda, Hansen Aaron, Wang Hui, Krishnan Suba, Norwood Kevin G and Doi Toshihiko. 20210412. Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the KEYNOTE-158 and KEYNOTE-028 studies. : International journal of cancer.
Harvard
Piha-Paul S. A., Oh D., Ueno M., Malka D., Chung H. C., Nagrial A., Kelley R. K., Ros W., Italiano A., Nakagawa K., Rugo H. S., de Braud F., Varga A. I., Hansen A., Wang H., Krishnan S., Norwood K. G. and Doi T. (20210412). Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the KEYNOTE-158 and KEYNOTE-028 studies. : International journal of cancer.
MLA
Piha-Paul Sarina A, Oh Do-Youn, Ueno Makoto, Malka David, Chung Hyun Cheol, Nagrial Adnan, Kelley Robin K, Ros Willeke, Italiano Antoine, Nakagawa Kazuhiko, Rugo Hope S, de Braud Filippo, Varga Andrea Iolanda, Hansen Aaron, Wang Hui, Krishnan Suba, Norwood Kevin G and Doi Toshihiko. Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the KEYNOTE-158 and KEYNOTE-028 studies. : International journal of cancer. 20210412.